Lipid peroxidation in Alzheimer’s Disease: emphasis on metal-mediated neurotoxicity

Evans, 1989, Prevalence of Alzheimer’s disease in a community population of older persons. Higher than previously reported, JAMA, 262, 2551, 10.1001/jama.262.18.2551

Lovell, 2007, Oxidative damage in mild cognitive impairment and early Alzheimer’s disease, J Neurosci Res, 85, 3036, 10.1002/jnr.21346

Bales, 2010, Brain lipid metabolism, apolipoprotein E and the pathophysiology of Alzheimer’s disease, Neuropharmacology, 59, 295, 10.1016/j.neuropharm.2010.01.005

Moreira, 2010, Detection and localization of markers of oxidative stress by in situ methods: application in the study of Alzheimer disease, Methods Mol Biol, 610, 419, 10.1007/978-1-60327-029-8_25

Obulesu, 2010, DNA damage and impairment of DNA repair in Alzheimer’s Disease, Int J Neurosci, 120, 397, 10.3109/00207450903411133

Obulesu, 2010, Animal models of Alzheimer’s Disease: an understanding of pathology and therapeutic avenues, Int J Neurosci, 120, 531, 10.3109/00207451003760080

Obulesu, 2009, Studies on genomic DNA stability in aluminium maltolate treated aged New Zealand rabbit: relevance to the Alzheimer’s animal model, J Clin Med Res, 1, 212

Dai, 2007, Protective effects of vitamin E against oxidative damage induced by Abeta1-40Cu(II) complexes, Acta Biochim Biophys Sin (Shanghai), 39, 123, 10.1111/j.1745-7270.2007.00261.x

Grundman, 2000, Vitamin E and Alzheimer disease: the basis for additional clinical trials, Am J Clin Nutr, 7, 630S, 10.1093/ajcn/71.2.630s

Sayre, 2005, Metal ions and oxidative protein modification in neurological disease, Ann Ist Super Sanita, 41, 143

Sayre, 1999, Redox metals and neurodegenerative disease, Curr Opin Chem Biol, 3, 220, 10.1016/S1367-5931(99)80035-0

Finefrock, 2003, Current status of metals as therapeutic targets in Alzheimer’s disease, J Am Geriatr Soc, 51, 1143, 10.1046/j.1532-5415.2003.51368.x

Sayre, 2000, The role of metals in neurodegenerative diseases, Cell Mol Biol, 46, 731

Zheng, 2006, Novel neuroprotective neurotrophic NAP analogs targeting metal toxicity and oxidative stress: potential candidates for the control of neurodegenerative diseases, J Neural Transm Suppl, 71, 163, 10.1007/978-3-211-33328-0_18

Sayre, 2000, In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer’s disease: a central role for bound transition metals, J Neurochem, 74, 270, 10.1046/j.1471-4159.2000.0740270.x

Stankiewicz, 2009, Role of iron in neurotoxicity: a cause for concern in the elderly?, Curr Opin Clin Nutr Metab Care, 12, 22, 10.1097/MCO.0b013e32831ba07c

Brass, 2006, Magnetic resonance imaging of iron deposition in neurological disorders, Top Magn Reson Imaging, 17, 31, 10.1097/01.rmr.0000245459.82782.e4

Smith, 1997, Iron accumulation in Alzheimer disease is a source of redoxgenerated free radicals, Proc Natl Acad Sci USA, 94, 9866, 10.1073/pnas.94.18.9866

Lovell, 1998, Copper, iron and zinc in Alzheimer’s disease senile plaques, J Neurol Sci, 158, 47, 10.1016/S0022-510X(98)00092-6

Bush, 2003, The metallobiology of Alzheimer’s disease, Trends Neurosci, 26, 207, 10.1016/S0166-2236(03)00067-5

Nadal, 2008, Amyloid beta-Cu2+ complexes in both monomeric and fibrillar forms do not generate H2O2 catalytically but quench hydroxyl radicals, Biochemistry, 47, 11653, 10.1021/bi8011093

Hayashi, 2007, Lipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-beta peptide, Free Radic Biol Med, 43, 1552, 10.1016/j.freeradbiomed.2007.08.013

Sayre, 1997, 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer’s disease, J Neurochem, 68, 2092, 10.1046/j.1471-4159.1997.68052092.x

Huang, 1999, Cu(II) potentiation of Alzheimer Aβ neurotoxicity: correlation with cell-free hydrogen peroxide production and metal reduction, J Biol Chem, 274, 37111, 10.1074/jbc.274.52.37111

Smith, 2000, Oxidative stress in Alzheimer’s disease, Biochim Biophys Acta, 1502, 139, 10.1016/S0925-4439(00)00040-5

Curtain, 2001, Alzheimer’s disease amyloid-β binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits, J Biol Chem, 276, 20466, 10.1074/jbc.M100175200

Dai, 2006, Cu(II) potentiation of Alzheimer Aβ1-40 cytotoxicity and transition on its secondary structure, Acta Biochim Biophys Sin, 38, 765, 10.1111/j.1745-7270.2006.00228.x

Munoz, 2002, Vitamin E not 17 estradiol protects against vascular toxicity induced by amyloid wild type and the dutch amyloid variant, J Neurosci, 22, 3081, 10.1523/JNEUROSCI.22-08-03081.2002

Brawer, 1994, Composition of Gomori-positive inclusions in astrocytes of the hypothalamic arcuate nucleus, Anat Rec, 240, 407, 10.1002/ar.1092400313

Schipper, 1998, Astrocyte mitochondria: a substrate for iron deposition in the aging rat substantia nigra, Exp Neurol, 152, 188, 10.1006/exnr.1998.6854

Castellani, 2001, Active glycation in neurofibrillary pathology of Alzheimer’s disease: Nε-(Carboxymethyl) lysine and hexitol-lysine, Free Radic Biol Med, 31, 175, 10.1016/S0891-5849(01)00570-6

Harman, 1956, Aging: a theory based on free radical and radiation chemistry, J Gerontol, 11, 298, 10.1093/geronj/11.3.298

Chance, 1979, Hydroperoxide metabolism in mammalian organs, Physiol Rev, 59, 527, 10.1152/physrev.1979.59.3.527

Martin, 2009, Role of human aldo-keto-reductase AKR1B10 in the protection against toxic aldehydes, Chem Biol Interact, 178, 145, 10.1016/j.cbi.2008.10.021

Atamna, 2007, Mechanisms of mitochondrial dysfunction and energy deficiency in Alzheimer’s disease, Mitochondrion, 7, 297, 10.1016/j.mito.2007.06.001

Yao, 2009, Mitochondrial bioenergetic deficit precedes Alzheimer’s pathology in female mouse model of Alzheimer’s disease, Proc Nat Acad Sci USA, 106, 14670, 10.1073/pnas.0903563106

Braidy, 2008, Promotion of cellular NAD+ anabolism: therapeutic potential for oxidative stress in ageing and Alzheimer’s disease, Neurotox Res, 13, 173, 10.1007/BF03033501

Ferrera, 2008, Cholesterol potentiates beta-amyloid-induced toxicity in human neuroblastoma cells: involvement of oxidative stress, Neurochem Res, 33, 1509, 10.1007/s11064-008-9623-y

Markesbery, 2006, DNA oxidation in Alzheimer’s disease, Antioxid Redox Signal, 8, 2039, 10.1089/ars.2006.8.2039

Liu, 2010, The protective effect of trihexyphenidyl on the beta-amyloid peptide (25-35)-induced cytotoxicity in PC12 cells, Clin Exp Med, 10, 237, 10.1007/s10238-010-0090-9

Gunasingh, 2008, Promotion of cellular NAD+ anabolism: therapeutic potential for oxidative stress in ageing and Alzheimer’s disease, Life Sci, 83, 96, 10.1016/j.lfs.2008.05.011

Huang, 2008, Protective effect of new S-acylglutathione derivatives against amyloid-induced oxidative stress, Phytomedicine, 15, 710, 10.1016/j.phymed.2008.02.022

Pensalfini, 2008, Cholesterol potentiates beta-amyloid-induced toxicity in human neuroblastoma cells: involvement of oxidative stress, Free Radic Biol Med, 144, 1624, 10.1016/j.freeradbiomed.2008.01.025

Jesudason, 2008, Inhibitory effects of short-term administration of DL-alpha-lipoic acid on oxidative vulnerability induced by Abeta amyloid fibrils (25-35) in mice, Mol Cell Biochem, 11, 145, 10.1007/s11010-008-9705-9

Eliuk, 2007, Active site modifications of the brain isoform of creatine kinase by 4-hydroxy-2-nonenal correlate with reduced enzyme activity: mapping of modified sites by Fourier transform-ion cyclotron resonance mass spectrometry, Chem Res Toxicol, 20, 1260, 10.1021/tx7000948

Dmitriev, 2007, Shortage of lipid-radical cycles in membranes as a possible prime cause of energetic failure in aging and Alzheimer disease, Neurochem Res, 32, 1278, 10.1007/s11064-007-9322-0

Jaffrey, 1995, Nitric oxide: a neural messenger, Annu Rev Cell Dev Biol, 11, 417, 10.1146/annurev.cb.11.110195.002221

Nathan, 1994, Nitric oxide synthases: roles, tolls, and controls, Cell, 78, 915, 10.1016/0092-8674(94)90266-6

Akiyama, 2000, Inflammation and Alzheimer’s disease, Neurobiol Aging, 21, 383, 10.1016/S0197-4580(00)00124-X

Drapier, 1988, Interferon-gamma and tumor necrosis factor induce the L-arginine-dependent cytotoxic effector mechanism in murine macrophages, Eur J Immunol, 18, 1587, 10.1002/eji.1830181018

Dawson, 1993, Nitric oxide as a mediator of neurotoxicity, NIDA Res Monogr, 136, 258

Dawson, 1998, Nitric oxide in neurodegeneration, Prog Brain Res, 118, 215, 10.1016/S0079-6123(08)63210-0

Ebadi, 2003, Peroxynitrite and mitochondrial dysfunction in the pathogenesis of Parkinson’s disease, Antioxid Redox Signal, 5, 319, 10.1089/152308603322110896

Iravani, 2002, Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration, Neuroscience, 110, 49, 10.1016/S0306-4522(01)00562-0

Vodovotz, 1996, Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer’s disease, J Exp Med, 184, 1425, 10.1084/jem.184.4.1425

Furchgott, 1980, The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine, Nature, 288, 373, 10.1038/288373a0

Murad, 1998, Nitric oxide signaling: would you believe that a simple free radical could be a second messenger, autacoid, paracrine substance, neurotransmitter, and hormone?, Recent Prog Horm Res, 53, 43

Endoh, 1994, Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia, Brain Res, 651, 92, 10.1016/0006-8993(94)90683-1

Satake, 2000, Nitric oxide via macrophage iNOS induces apoptosis following traumatic spinal cord injury, Brain Res Mol Brain Res, 85, 114, 10.1016/S0169-328X(00)00253-9

Wada, 1998, Role of nitric oxide in traumatic brain injury in the rat, J Neurosurg, 89, 807, 10.3171/jns.1998.89.5.0807

Kochman, 2002, Submolecular adventures of brain tyrosine: what are we searching for now?, Amino Acids, 23, 95, 10.1007/s00726-001-0114-6

Moncada, 1993, The L-arginine-nitric oxide pathway, N Engl J Med, 329, 2002, 10.1056/NEJM199312303292706

Bolanos, 1997, Nitric oxide-mediated mitochondrial damage in the brain: mechanisms and implications for neurodegenerative diseases, J Neurochem, 68, 2227, 10.1046/j.1471-4159.1997.68062227.x

Pannu, 2006, Pharmacological strategies for the regulation of inducible nitric oxide synthase: neurodegenerative versus neuroprotective mechanisms, Neurochem Int, 49, 170, 10.1016/j.neuint.2006.04.010

Stuehr, 1999, Mammalian nitric oxide synthases, Biochim Biophys Acta, 1411, 217, 10.1016/S0005-2728(99)00016-X

Ignarro, 1999, Nitric oxide as a signaling molecule in the vascular system: an overview, J Cardiovasc Pharmacol, 34, 879, 10.1097/00005344-199912000-00016

Popp, 1998, Pulsatile stretch in coronary arteries elicits release of endothelium-derived hyperpolarizing factor: a modulator of arterial compliance, Circ Res, 82, 696, 10.1161/01.RES.82.6.696

Knowles, 1994, Nitric oxide synthases in mammals, Biochem J, 298, 249, 10.1042/bj2980249

Satoh, 2010, Anti-cyclic citrullinated peptide antibody (anti-CCP antibody) is present in the sera of patients with dementia of Alzheimer’s type in Asian, Acta Neurol Scand, 121, 338, 10.1111/j.1600-0404.2009.01217.x

Pablo, 2009, Cyanobacterial neurotoxin BMAA in ALS and Alzheimer’s disease, Acta Neurol Scand, 120, 216, 10.1111/j.1600-0404.2008.01150.x

Stamler, 1994, Redox signaling: nitrosylation and related target interactions of nitric oxide, Cell, 78, 931, 10.1016/0092-8674(94)90269-0

Beckman, 1996, Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly, Am J Physiol, 271, C1424, 10.1152/ajpcell.1996.271.5.C1424

Wang, 2009, Ginsenoside Rg1 inhibits beta-secretase activity in vitro and protects against Abeta-induced cytotoxicity in PC12 cells, J Asian Nat Prod Res, 11, 604, 10.1080/10286020902843152

Leeuwenburgh, 1998, Markers of protein oxidation by hydroxyl radical and reactive nitrogen species in tissues of aging rats, Am J Physiol, 274, R453

Matthews, 1996, Increased 3-nitrotyrosine in brains of Apo E-deficient mice, Brain Res, 718, 181, 10.1016/0006-8993(95)01576-0

Smith, 1997, Widespread peroxynitrite-mediated damage in Alzheimer’s disease, J Neurosci, 17, 2653, 10.1523/JNEUROSCI.17-08-02653.1997

Kumar, 2006, Differential effects of cyclooxygenase inhibitors on intracerebroventricular colchicine-induced dysfunction and oxidative stress in rats, Eur J Pharmacol, 551, 58, 10.1016/j.ejphar.2006.08.076

Adlard, 2008, Rapid restoration of cognition in Alzheimer’s transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta, Neuron, 59, 43, 10.1016/j.neuron.2008.06.018

Reddy, 2009, Oxidative stress in diabetes and Alzheimer’s disease, J Alzheimers Dis, 16, 763, 10.3233/JAD-2009-1013

Crapper McLachlan, 1991, Intramuscular desferrioxamine in patients with Alzheimer’s disease, Lancet, 337, 1304, 10.1016/0140-6736(91)92978-B